AREV Life Sciences Global Corp. (AREV.CN) Comparison with companies in other sectors?

AREV Life Sciences Global Corp. has a share price of 31.76M. You can analyze AREV Life Sciences Global Corp. (AREV.CN) competitors across different market sectors through stock heatmaps.

What are AREV.CN's NET and operating margins?

AREV Life Sciences Global Corp. (AREV.CN) operating margin is around -28.40, and net profit margin is approximately -29.40 as of the latest reports.

In what way does AREV.CN's earnings per share (EPS) trend reflect its financial momentum?

AREV Life Sciences Global Corp. (AREV.CN) EPS is -0.04 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for AREV Life Sciences Global Corp. is -2.25, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for AREV Life Sciences Global Corp.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for AREV Life Sciences Global Corp. like P/E which is -1.87, P/B which is -2.84, and PEG which is -0.02. Compare them with sector averages to evaluate if the stock is priced fairly.

AREV Life Sciences Global Corp.

AREV.CN•CNQ

Healthcare

Drug Manufacturers - Specialty & Generic

CA$0.09

CA$0.00(0.00%)

AREV Life Sciences Global Corp. (AREV.CN) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.04

P/E Ratio

-2.25

ROE

2.76%

Net Margin

-29.40%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.86M

Shares OutstandingTotal number of shares issued

$31.76M

Book Value/ShareNet worth per share

$-0.03

Revenue/ShareAnnual revenue per share

$0.002

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.04

Net MarginNet income as percentage of revenue

-2940.37%

Operating MarginOperating income as percentage of revenue

-2839.86%

ROEReturn on shareholders' equity

276.09%

ROAReturn on total assets

-571.63%

ROCEReturn on capital employed

146.41%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.01

Cash/ShareCash and equivalents per share

$0.00

FCF YieldFree cash flow as percentage of market cap

-12.81%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for AREV.CNFinancial Ratios Analysis details for AREV.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AREV.CNSector Benchmarking details for AREV.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for AREV Life Sciences Global Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of AREV Life Sciences Global Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account AREV Life Sciences Global Corp.'s unique business strengths and challenges.

Key Financial Metrics for AREV Life Sciences Global Corp.

For AREV Life Sciences Global Corp., essential financial indicators include EPS -0.04, PE -2.25, and ROE 2.76. These key ratios reveal insights into AREV Life Sciences Global Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare AREV Life Sciences Global Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of AREV Life Sciences Global Corp.

Metrics like Net Margin -2940.37% and ROA -571.63% shed light on how well AREV Life Sciences Global Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether AREV Life Sciences Global Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of AREV Life Sciences Global Corp.

Using ratios such as P/B Ratio -2.84 and PEG Ratio -0.02, investors can assess whether AREV Life Sciences Global Corp. is appropriately valued based on its financials and growth potential. These figures, combined with AREV Life Sciences Global Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for AREV Life Sciences Global Corp.

Financial health indicators, such as Debt/Equity Ratio -0.03 and Cash Flow $-0.01, provide a snapshot of AREV Life Sciences Global Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like AREV Life Sciences Global Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for AREV Life Sciences Global Corp.

Investing in AREV Life Sciences Global Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at AREV Life Sciences Global Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;